572 related articles for article (PubMed ID: 31138779)
1. Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment.
Lv J; Jia Y; Li J; Kuai W; Li Y; Guo F; Xu X; Zhao Z; Lv J; Li Z
Cell Death Dis; 2019 May; 10(6):415. PubMed ID: 31138779
[TBL] [Abstract][Full Text] [Related]
2. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients
Li Y; Li ZX; Xie CY; Fan J; Lv J; Xu XJ; Lv J; Kuai WT; Jia YT
World J Gastroenterol; 2020 Dec; 26(48):7633-7651. PubMed ID: 33505141
[TBL] [Abstract][Full Text] [Related]
3. Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.
Yu G; Wu Y; Wang W; Xu J; Lv X; Cao X; Wan T
Cell Mol Immunol; 2019 Apr; 16(4):401-409. PubMed ID: 29622799
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine.
Xu X; Gao Z; Yang F; Yang Y; Chen L; Han L; Zhao N; Xu J; Wang X; Ma Y; Shu L; Hu X; Lyu N; Pan Y; Zhu B; Zhao L; Tong X; Wang J
Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):721-736. PubMed ID: 33359679
[TBL] [Abstract][Full Text] [Related]
5. GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora.
Deng L; Shi Y; Liu P; Wu S; Lv Y; Xu H; Chen X
Biomed Pharmacother; 2021 Sep; 141():111896. PubMed ID: 34246956
[TBL] [Abstract][Full Text] [Related]
6. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
7. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
8. Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq.
Li Y; Gong Y; Zhang X; Wang J; Cheng Y; Liu F; Shi X; Xu W; Dong L
J Ethnopharmacol; 2021 Oct; 278():114283. PubMed ID: 34098017
[TBL] [Abstract][Full Text] [Related]
9. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
10. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
[TBL] [Abstract][Full Text] [Related]
11. [Compatibility mechanism of Gegen Qinlian Decoction in treatment of ulcerative colitis based on network pharmacology].
Li T; Liu F; Zhang XY; Xu MS; Zhao Y; Sun J; Xu WJ; Dong L
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3619-3628. PubMed ID: 35850816
[TBL] [Abstract][Full Text] [Related]
12. Gegen-Qinlian decoction alleviates anxiety-like behaviors in methamphetamine-withdrawn mice by regulating Akkermansia and metabolism in the colon.
Lu X; Fan Y; Peng Y; Pan W; Du D; Xu X; Li N; He T; Nie J; Shi P; Ge F; Liu D; Chen Y; Guan X
Chin Med; 2023 Jul; 18(1):85. PubMed ID: 37455317
[TBL] [Abstract][Full Text] [Related]
13. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
Tian J; Bai B; Gao Z; Yang Y; Wu H; Wang X; Wang J; Li M; Tong X
Front Cell Infect Microbiol; 2021; 11():740236. PubMed ID: 34692563
[TBL] [Abstract][Full Text] [Related]
14. Combination of Fruquintinib and Anti-PD-1 for the Treatment of Colorectal Cancer.
Wang Y; Wei B; Gao J; Cai X; Xu L; Zhong H; Wang B; Sun Y; Guo W; Xu Q; Gu Y
J Immunol; 2020 Nov; 205(10):2905-2915. PubMed ID: 33028620
[TBL] [Abstract][Full Text] [Related]
15. Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection.
Shi Y; Xu H; Xiao Y; Liu P; Pang P; Wu S; Deng L; Chen X
Biomed Pharmacother; 2020 Jan; 121():109471. PubMed ID: 31707346
[TBL] [Abstract][Full Text] [Related]
16. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
17. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.
Liu X; Fan Y; Du L; Mei Z; Fu Y
Front Pharmacol; 2021; 12():665102. PubMed ID: 34177580
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.
Wu Y; Wang D; Yang X; Fu C; Zou L; Zhang J
Biomed Pharmacother; 2019 Jan; 109():2252-2261. PubMed ID: 30551482
[TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology-Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer.
Fan Q; Guo L; Guan J; Chen J; Fan Y; Chen Z; Li H
Evid Based Complement Alternat Med; 2020; 2020():8897879. PubMed ID: 33294000
[TBL] [Abstract][Full Text] [Related]
20. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
